|
1.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J
Clin. 2013;63:11-30.
http://dx.doi.org/10.3322/caac.21166
|
|
|
|
2.
Marocchio LS, Lima J, Sperandio FF, Correa L, de Sousa SO. Oral squamous
cell carcinoma: an analysis of 1,564 cases showing advances in early
detection. Journal of oral science. 2010;52:267-73.
http://dx.doi.org/10.2334/josnusd.52.267
|
|
|
|
|
3.
Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, et al.
Prognostic factors in tongue cancer - relative importance of demographic,
clinical and histopathological factors. British journal of cancer.
2000;83:614-9.
http://dx.doi.org/10.1054/bjoc.2000.1323
|
|
|
|
|
4.
van der Schroeff MP, Baatenburg de Jong RJ. Staging and prognosis in head
and neck cancer. Oral oncology. 2009;45:356-60.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.022
|
|
|
|
|
5.
Nixon IJ, Palmer FL, Lakin P, Kattan MM, Lee NY, Ganly I. Pathologically
determined tumor volume vs pathologic T stage in the prediction of
outcome after surgical treatment of oropharyngeal squamous cell
carcinoma. JAMA otolaryngology-- head & neck surgery.
2013;139:1151-5.
http://dx.doi.org/10.1001/jamaoto.2013.4973
|
|
|
|
|
6.
Wangsa D, Ryott M, Avall-Lundqvist E, Petersson F, Elmberger G, Luo J, et
al. Ki-67 expression predicts locoregional recurrence in stage I oral
tongue carcinoma. British journal of cancer. 2008;99:1121-8.
http://dx.doi.org/10.1038/sj.bjc.6604633
|
|
|
|
|
7.
Giudice FS, Dal Vechio AM, Abrahao AC, Sperandio FF, Pinto-Junior Ddos S.
Different expression patterns of pAkt, NF-kappaB and cyclin D1 proteins
during the invasion process of head and neck squamous cell carcinoma: an
in vitro approach. Journal of oral pathology & medicine : official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2011;40:405-11.
http://dx.doi.org/10.1111/j.1600-0714.2010.00960.x
|
|
|
|
|
8.
Sperandio FF, Giudice FS, Corra L, Pinto DS, Hamblin MR, de Sousa SC.
Low-level laser therapy can produce increased aggressiveness of
dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling
pathway. J Biophotonics. 2013;6:839-47.
http://dx.doi.org/10.1002/jbio.201300015
|
|
|
|
|
9.
Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, et al.
Creating oral squamous cancer cells: a cellular model of oral-esophageal
carcinogenesis. Proceedings of the National Academy of Sciences of the
United States of America. 2005;102:15599-604.
http://dx.doi.org/10.1073/pnas.0409730102
|
|
|
|
|
10.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer
statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
http://dx.doi.org/10.3322/CA.2007.0010
|
|
|
|
|
11.
Lam L, Logan RM, Luke C. Epidemiological analysis of tongue cancer in
South Australia for the 24-year period, 1977-2001. Australian dental
journal. 2006;51:16-22.
http://dx.doi.org/10.1111/j.1834-7819.2006.tb00395.x
|
|
|
|
|
12.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer.
Oral oncology. 2009;45:309-16.
http://dx.doi.org/10.1016/j.oraloncology.2008.06.002
|
|
|
|
|
13.
Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer:
means, markers and perspectives (I). Oral oncology. 2010;46:630-5.
http://dx.doi.org/10.1016/j.oraloncology.2010.06.006
|
|
|
|
|
14.
Bagan JV, Scully C. Recent advances in Oral Oncology 2007: epidemiology,
aetiopathogenesis, diagnosis and prognostication. Oral oncology.
2008;44:103-8.
http://dx.doi.org/10.1016/j.oraloncology.2008.01.008
|
|
|
|
|
15.
Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New
malignancy grading is a better prognostic indicator than Broders' grading
in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18:432-7.
http://dx.doi.org/10.1111/j.1600-0714.1989.tb01339.x
|
|
|
|
|
16.
Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, et al.
Abnormal beta-catenin expression in oral cancer with no gene mutation:
correlation with expression of cyclin D1 and epidermal growth factor
receptor, Ki-67 labeling index, and clinicopathological features. Human
pathology. 2005;36:234-41.
http://dx.doi.org/10.1016/j.humpath.2004.12.009
|
|
|
|
|
17.
Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lpez-Arranz JS.
Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral
cavity: clinicopathological and prognostic significance. Oral Oncol.
2002;38:301-8.
http://dx.doi.org/10.1016/S1368-8375(01)00060-4
|
|
|
|
|
18.
Petersen PE. Oral cancer prevention and control--the approach of the
World Health Organization. Oral oncology. 2009;45:454-60.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.023
|
|
|
|
|
19.
Petti S. Lifestyle risk factors for oral cancer. Oral oncology.
2009;45:340-50.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.018
|
|
|
|
|
20.
Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell
carcinoma: review of prognostic and predictive factors. Oral surgery,
oral medicine, oral pathology, oral radiology, and endodontics.
2006;102:67-76.
http://dx.doi.org/10.1016/j.tripleo.2005.07.038
|
|
|
|
|
21.
Henriques AC, de Matos FR, Galvao HC, Freitas Rde A. Immunohistochemical
expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Journal of oral science. 2012;54:105-11.
http://dx.doi.org/10.2334/josnusd.54.105
|
|
|
|
|
22.
Mohtasham N, Mahdavi-Shahri N, Salehinejad J, Ejtehadi H, Torabi-Parizi
M, Ghazi N. Detection of nucleoproteins in squamous cell carcinoma, and
dysplastic and normal mucosa in the oral cavity by methyl green-pyronin
staining. Journal of oral science. 2010;52:239-43.
http://dx.doi.org/10.2334/josnusd.52.239
|
|
|
|
|
23.
Marsit CJ, Black CC, Posner MR, Kelsey KT. A Genotype-Phenotype
Examination of Cyclin D1 on Risk and Outcome of Squamous Cell Carcinoma
of the Head and Neck. Clin Cancer Res. 2008;14:2371-7.
http://dx.doi.org/10.1158/1078-0432.CCR-07-4368
|
|
|
|
|
24.
Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. Molecular introduction
to head and neck cancer (HNSCC) carcinogenesis. British journal of
plastic surgery. 2004;57:595-602.
http://dx.doi.org/10.1016/j.bjps.2004.06.010
|
|
|
|
|
25.
Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther.
2002;1:226-31.
http://dx.doi.org/10.4161/cbt.72
|
|
|
|
|
26.
Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N,
Aghamohammadi M, et al. Cyclin D1 amplification and p16(MTS1/CDK4I)
deletion correlate with poor prognosis in head and neck tumors. The
Laryngoscope. 2002;112:472-81.
http://dx.doi.org/10.1097/00005537-200203000-00013
|
|
|
|
|
27.
Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential
expression and activation of NF-kappaB family proteins during oral
carcinogenesis: Role of high risk human papillomavirus infection.
International journal of cancer Journal international du cancer.
2006;119:2840-50.
http://dx.doi.org/10.1002/ijc.22262
|
|
|
|
|
28.
Ondrey FG, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, et al.
Constitutive activation of transcription factors NF-(kappa)B, AP-1, and
NF-IL6 in human head and neck squamous cell carcinoma cell lines that
express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog.
1999;26:119-29.
http://dx.doi.org/10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N
|
|
|
|
|
29.
Reich NC, Liu L. Tracking STAT nuclear traffic. Nature reviews
Immunology. 2006;6:602-12.
http://dx.doi.org/10.1038/nri1885
|
|
|
|
|
30.
Salgueiredo-Giudice F, Correa-Abrahao A, Fornias-Sperandio F,
da-Costa-Dal-Vechio AM, dos-Santos-Pinto-Junior D. An in vitro study
showing the three-dimensional microenvironment influence over the
behavior of head and neck squamous cell carcinoma. Medicina oral,
patologia oral y cirugia bucal. 2012;17:e377-82.
http://dx.doi.org/10.4317/medoral.17538
|
|
|
|
|
31.
Vieira RAMAR, Minicucci EM, Marques MEA, Marques SA. Actinic cheilitis
and squamous cell carcinoma of the lip: clinical, histopathological and
immunogenetic aspects. An Bras Dermatol. 2012;87:105-14.
|
|
|
|
|
32.
Fujii M, Ishiguro R, Yamashita T, Tashiro M. Cyclin D1 amplification
correlates with early recurrence of squamous cell carcinoma of the
tongue. Cancer Lett. 2001;172:187-92.
http://dx.doi.org/10.1016/S0304-3835(01)00651-6
|
|
|
|
|
33.
Wang L, Liu T, Nishioka M, Aguirre RL, Win SS, Okada N. Activation of
ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas:
relationship between clinicopathological appearances and cell
proliferation. Oral oncology. 2006;42:625-31.
http://dx.doi.org/10.1016/j.oraloncology.2005.11.002
|
|
|
|
|
34.
Abrahao AC, Giudice FS, Sperandio FF, Pinto Junior Ddos S. Effects of
celecoxib treatment over the AKT pathway in head and neck squamous cell
carcinoma. Journal of oral pathology & medicine : official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2013;42:793-8.
http://dx.doi.org/10.1111/jop.12081
|
|
|
|
|
35.
Kovesi G, Szende B. Prognostic value of cyclin D1, p27, and p63 in oral
leukoplakia. Journal of oral pathology & medicine : official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2006;35:274-7.
http://dx.doi.org/10.1111/j.1600-0714.2006.00396.x
|
|
|
|
|
36.
Turatti E, da Costa Neves A, de Magalhaes MH, de Sousa SO. Assessment of
c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
Journal of oral science. 2005;47:71-6.
http://dx.doi.org/10.2334/josnusd.47.71
|
|
|
|
|
37.
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle
analysis of a cell proliferation-associated human nuclear antigen defined
by the monoclonal antibody Ki-67. Journal of immunology. 1984;133:1710-5.
|
|
|
|
|
38.
Faratzis G, Tsiambas E, Rapidis AD, Machaira A, Xiromeritis K, Patsouris
E. VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An
immunohistochemical and computerized image analysis study. Oral oncology.
2009;45:584-8.
http://dx.doi.org/10.1016/j.oraloncology.2008.08.002
|
|
|
|
|
39.
Thomson PJ, Hamadah O, Goodson ML, Cragg N, Booth C. Predicting
recurrence after oral precancer treatment: use of cell cycle analysis.
The British journal of oral & maxillofacial surgery. 2008;46:370-5.
http://dx.doi.org/10.1016/j.bjoms.2008.01.003
|
|
|
|
|
40.
Kumar P, Kane S, Rathod GP. Coexpression of p53 and Ki 67 and lack of
c-erbB2 expression in oral leukoplakias in India. Brazilian oral
research. 2012;26:228-34.
http://dx.doi.org/10.1590/S1806-83242012000300008
|
|
|
|
|
41.
Yu YH, Morales J, Feng L, Lee JJ, El-Naggar AK, Vigneswaran N. CD147 and
Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of
oral tongue: a tissue microarray study. Oral Surg Oral Med Oral Pathol
Oral Radiol. 2015;119:553-65.
http://dx.doi.org/10.1016/j.oooo.2014.12.022
|
|
|
|
|
42.
Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehlsing M, Eckel HE.
Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the
oropharynx and oral cavity. Oral Oncol. 1999;35:583-9.
http://dx.doi.org/10.1016/S1368-8375(99)00041-X
|
|
|
|
|
43.
Vogin G, Foray N. The law of Bergonie and Tribondeau: a nice formula for
a first approximation. International journal of radiation biology.
2013;89:2-8.
http://dx.doi.org/10.3109/09553002.2012.717732
|
|
|
|
|
44.
Martinez A, Brethauer U, Rojas IG, Spencer M, Mucientes F, Borlando J, et
al. Expression of apoptotic and cell proliferation regulatory proteins in
actinic cheilitis. Journal of oral pathology & medicine : official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2005;34:257-62.
http://dx.doi.org/10.1111/j.1600-0714.2004.00299.x
|
|
|
|
|
45.
Montebugnoli L, Gissi DB, Badiali G, Marchetti C, Cervellati F, Farnedi
A, et al. Ki-67 from clinically and histologically "normal"
distant mucosa as prognostic marker in early-stage (T1-T2N0) oral
squamous cell carcinoma: a prospective study. Journal of oral and
maxillofacial surgery : official journal of the American Association of
Oral and Maxillofacial Surgeons. 2011;69:2579-84.
http://dx.doi.org/10.1016/j.joms.2010.10.041
|
|
|
|
|
46.
Nguyen DH, Truong PT. A debate on locoregional treatment of the primary
tumor in patients presenting with stage IV breast cancer. Expert review
of anticancer therapy. 2011;11:1913-22.
http://dx.doi.org/10.1586/era.11.168
|
|
|
|
|
47.
Hanemann JA, Oliveira DT, Nonogaki S, Nishimoto IN, de Carli ML, Landman
G, et al. Expression of E-cadherin and beta-catenin in basaloid and
conventional squamous cell carcinoma of the oral cavity: are potential
prognostic markers? BMC cancer. 2014;14:395.
http://dx.doi.org/10.1186/1471-2407-14-395
|
|
|
|
|
48.
Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Okamune A, Sugiura S, et
al. Expression form of p53 and PCNA at the invasive front in oral
squamous cell carcinoma: correlation with clinicopathological features
and prognosis. Journal of oral pathology & medicine: official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2011;40:693-8.
http://dx.doi.org/10.1111/j.1600-0714.2011.01032.x
|
|
|
|
|
49.
Lakhani SR, Ashworth A. Microarray and histopathological analysis of
tumours: the future and the past? Nature reviews Cancer. 2001;1:151-7.
http://dx.doi.org/10.1038/35101087
|
|
|
|